Description

Lamotrin-25 tablets 25 mg. №30

Ingredients:

Each tablet contains 25 mg of Lamotrigine.

Dosage:

The recommended dosage is determined by a healthcare provider based on individual needs. It is usually started at a low dose and gradually increased to achieve the desired therapeutic effect.

Indications:

Lamotrin-25 tablets are indicated for the treatment of epilepsy in adults and children. It may be used alone or in combination with other antiepileptic medications.

Contraindications:

Do not use Lamotrin-25 tablets if you are allergic to Lamotrigine or any other ingredients in the formulation. It is important to consult a healthcare provider before starting this medication.

Directions:

Take Lamotrin-25 tablets orally with or without food as directed by your healthcare provider. Do not crush or chew the tablets. Follow the prescribed dosage regimen for best results.

Scientific Evidence:

Studies have shown that Lamotrigine is effective in reducing the frequency of seizures in patients with epilepsy. Research published in the Journal of Neurology indicates that Lamotrigine is well-tolerated and has a favorable efficacy profile in the treatment of epilepsy.

Additional Information:

It is important to follow up with regular medical appointments while taking Lamotrin-25 tablets to monitor for any potential side effects or adjustments in dosage. Inform your healthcare provider about any other medications or supplements you are taking to avoid interactions.

Lamotrigine, the active ingredient in Lamotrin-25 tablets, works by stabilizing electrical activity in the brain and reducing abnormal excitement that can lead to seizures. It is believed to modulate voltage-gated sodium channels and inhibit the release of glutamate, a neurotransmitter involved in seizure generation.

Clinical trials have demonstrated the efficacy of Lamotrigine in both newly diagnosed and refractory epilepsy. A study published in Epilepsia compared the effectiveness of Lamotrigine with other antiepileptic drugs and found it to be non-inferior in terms of seizure control and tolerability.